Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living with HIV: A Controlled Trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 1, 2016, Pages 38-46

  Brown, Larry K ^a   Kennard, Betsy D ^b   Emslie, Graham J ^b   Mayes, Taryn L ^b   Whiteley, Laura B ^a   Bethel, James ^c   Xu, Jiahong ^c   Thornton, Sarah ^c   Tanney, Mary R ^d   Hawkins, Linda A ^d   Garvie, Patricia A ^e   Subramaniam, Geetha A ^f   Worrell, Carol J ^g   Stoff, Laura W ^a   Kapogiannis, B ^g   Worrell, C ^g   Kahana, S ^h   Davenny, K ^h   Allison, S ⁱ   Emmanuel, ^j   Lujan Zilbermann, ^j   Julian, ^j   Douglas, ^d   Tanney, ^d   DiBenedetto, ^d   Futterman, ^k   Enriquez Bruce, ^k   Campos, ^k   Fernandez, ^k   Puga, ^e   Leonard, ^e   Inman, ^e   Flynn, ^l   Dillard, ^l   Wilkins, ^l   Wilson, C ^m   Partlow, C ^m   Korelitz, J ^c   Driver, B ^c   more..

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WESTAT   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e Children's Diagnostic and Treatment Center   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h National Institute on Drugs Abuse   (United States)

ⁱ Molecular Neuroscience and Bioinformatics Laboratories   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k MONTEFIORE MEDICAL CENTER   (United States)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^m ATN Coordinating Center for Network for Scientific and Logistical Support   (United States)

more..

Author keywords

antidepressants; cognitive behavioral therapy; HIV; major depressive disorder; young adults; youth

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CD4 ANTIGEN; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DEPRESSION ASSESSMENT; DRUG DOSE TITRATION; EVENING DOSAGE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION THERAPY MANAGEMENT; MONOTHERAPY; MORNING DOSAGE; PRIORITY JOURNAL; QUICK INVENTORY OF DEPRESSIVE SYMPTOMOLOGY CLINICIAN RATING; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD; YOUNG ADULT; DEPRESSIVE DISORDER; MEDICATION COMPLIANCE; MULTIMODALITY CANCER THERAPY; OUTPATIENT DEPARTMENT; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 84951120269     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000803     Document Type: Article

References (49)

1. Gaughan DM, Hughes MD, Oleske JM, et al. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004;113:e544-e551.
2. Brown LK, Whiteley L, Harper GW, et al; Psychological symptoms among 2032 youth living with HIV: a multisite study. AIDS Patient Care STDS. 2015;29:212-219.
3. Martinez J, Hosek SG, Carleton RA. Screening and assessing violence and mental health disorders in a cohort of inner city HIV-positive youth between 1998-2006. AIDS Patient Care STDS. 2009;23:469-475.
4. Pao M, Lyon M, D'Angelo LJ, et al. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154:240-244.
5. Reisner SL, Mimiaga MJ, Skeer M, et al. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17:14-25.
6. Murphy DA, Belzer M, Durako SJ, et al; Adolescent Medicine HIV/AIDS Research Network. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159:764-770.
7. Caballero J, Nahata MC. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann Pharmacother. 2005; 39:141-145.
8. Elliott AJ, Russo J, Roy-Byrne PP. The effect of changes in depression on health related quality of life (HRQoL) in HIV infection. Gen Hosp Psychiatry. 2002;24:43-47.
9. Horberg MA, Silverberg SJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384-390.
10. Parsons JT, Golub SA, Rosof E, et al. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46:443-450.
11. Rosello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol. 1999;67:734-745.
12. Sweeney M, Robins M, Ruberu M, et al. African-American and Latino families in TADS: recruitment and treatment considerations. Cogn Behav Pract. 2005;12:221-229.
13. Castro-Couch M. Review of cognitive-behavioral therapies with lesbian, gay, and bisexual clients. Arch Sex Behav. 2007;36:626-627.
14. Safren SA, Rogers T. Cognitive-behavioral therapy with gay, lesbian, and bisexual clients. J Clin Psychol. 2007;57:629-643.
15. Birmaher B, Brent D; AACAP Work Group on Quality Issues, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-1526.
16. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics. 2007;120:E1313-E1326.
17. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132-1143.
18. Richardson L, Ludman E, McCauley E, et al. Collaborative care for adolescents in primary care. J Am Med Assoc. 2014;312:809-816.
19. Brown LK, Whiteley L, Harper GW, et al; Trials Network for HIV/AIDS Interventions. Psychological symptoms among 2032 youth living with HIV: a multisite study. AIDS Patient Care STDS. 2015;29:212-219.
20. Rudy BR, Murphy DA, Harris R, et al; Trials Network for HIV/AIDS Interventions. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009;23:185-193.
21. Henkel V, Bussfeld P, Mller H, et al. Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression? Eur Arch Psychiatry Clin Neurosci. 2002;252:240-249.
22. Rissanen T, Viinamäki H, Honkalampi K, et al. Long term life dissatisfaction and subsequent major depressive disorder and poor mental health. BMC Psychiatry. 2011;11:140.
23. Gelenberg A, Freeman M, Markowitz J, Rosenbaum J, Thase M, et al. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. The American Journal of Psychiatry, suppl. 2010;167:101-103,109-111,113-118.
24. American Psychiatric Association, and American Psychiatric Association. Work Group on HIV/AIDS. Practice guideline for the treatment of patients with HIV/AIDS. American Psychiatric Pub, 2000.
25. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-Analysis of randomized controlled trials. J Am Med Assoc. 2007;297:1683-1696.
26. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report. Am J Psychiatry. 2006;163:1905-1917.
27. Emslie GJ, Mayes T, Porta G, et al. Treatment of resistant depression in adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167: 782-791.
28. Hughes C, Emslie GJ, Crismon M, et al. Texas children's medication algorithm project: update for Texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:667-686.
29. Kennard B, Hayley C, Hughes J, et al. CBT Treatment Manual for ATN 080; 2010. Unpublished.
30. Naar-King S, Suarez M. Motivational Interviewing with Adolescents and Young Adults. New York, NY: Guilford Press; 2011.
31. Naar-King S, Parsons JT, Murphy DA, et al. Improving health outcomes for youth living with the human immunodeficiency virus a multisite randomized trial of motivational intervention targeting multiple risk behaviors. Arch Pediatr Adolesc Med. 2009;163:1092-1098.
32. Kennard BD, Brown LK, Hawkins L, et al. Development and implementation of health and wellness CBT for individuals with depression and HIV. Cogn Behav Pract. 2014;21:237-246.
33. Young J, Beck A. Cognitive therapy scale: rating manual. 1980. Unpublished manuscript.
34. Bernstein IH, Rush AJ, Trivedi MH, et al. Psychometric properties of the quick inventory of depressive symptomatology in adolescents. Int J Methods Psychiatr Res. 2010;19:185-194.
35. Moore HK, Hughes CW, Mundt JC, et al. A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology. J Clin Psychiatry. 2007;68:1436-1440.
36. Beck AT, Weissman A, Lester D, et al. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;4:861-865.
37. Brent DA, Kolko D, Birmaher B, et al. A clinical trial for adolescent depression: predictors of additional treatment in the acute and followup phases of the trial. J Am Acad Child Adolesc Psychiatry. 1999;38: 263-270.
38. Brent DA, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry. 1997;54:877-885.
39. Huebner ES. Preliminary development and validation of a multidimensional life satisfaction scale for children. Psychol Assess. 1994;6: 149-158.
40. Gilman R, Huebner EW, Laughlin JE. A first study of the multidimensional student life satisfaction scale with adolescents. Soc Indic Res. 2000;52:135-160.
41. Burns B, Angold A, Magruder-Habib K, et al. Child and Adolescent Services Assessment (Version 4.2). Durham, NC: Duke University; 1997.
42. Rubin DB. Inference and missing data. Biometrika. 1976;63:581-592.
43. Katon W, Lin EHB, Von Korf M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363: 2611-2620.
44. O'Neil A, Sanderson K, Oldenburg B, et al. Impact of depression treatment on mental and physical health-related quality of life of cardiac patients. J Cardiopulm Rehabil Prev. 2011;31:146-156.
45. Goodyear I, Dubicka B, Wilkinson P, et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomized controlled trial. BMJ. 2007;335:142.
46. Brent D, Emslie G, Clarke G, et al. The treatment of adolescents with SSRI-resistant depression (TORDIA): a comparison of switch to venlafaxine or to another SSRI, with or without additional cognitive behavioral therapy. J Am Med Assoc. 2008;299:901-913.
47. Warden D, Rush AJ, Trivedi MH, et al. The STAR D project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007;9:449-459.
48. Curry J, Silva S, Rohde P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry. 2011; 68:263-269.
49. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine vs. Placebo to prevent relapse of MDD in children and adolescents. Am J Psychiatry. 2008;165:459-467.